Director Kenneth Eugene Smith bought 308 shares at blended $25.26 on 2024-06-14; 4 prior BHB buys all showed positive 90-day returns with 100% timing accuracy.
Smith Kenneth Eugene (Director) executed 4 separate purchases totaling 308 shares for $7,799.82 on 2024-06-14, bringing his holdings to 24,507 shares (+1.3% increase). This is his fifth open-market purchase of BHB stock: his prior 4 buys at this ticker (all in March 2024) demonstrated consistent positive 90-day performance, with all 4 trades showing gains of +3.4% to +4.0% over the subsequent 90 days and initial 30-day dips of -2.4% to -3.8%, establishing a 100% well-timed buy pattern at this ticker. A cluster of 3 additional insiders buying within the same 14-day window signals coordinated accumulation. The company trades at a P/E of 9.45 with recent quarterly net income of $10.1M against revenue of $7.4M and 3.4% annual revenue growth; the stock is currently -13.6% from its 52-week high and down 5.7% over 30 days, creating a valuation backdrop for his purchase. His demonstrated execution record at this ticker warrants investor attention as a potential leading indicator of near-term price recovery.